ARS Pharmaceuticals, Inc. Prepaid Expense, Current
ARS Pharmaceuticals, Inc. (SPRY) had Prepaid Expense, Current of $1.28 million as of 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2025-11-10
- 2025-09-30: Prepaid Expense, Current $1.28M.
- 2025-03-31: Prepaid Expense, Current $8.34M.
- 2024-12-31: Prepaid Expense, Current $237.00K; Prepaid Expense, Current as first filed $3.41M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2025-09-30 | $1.28M 10-Q · filed 2025-11-10 | |
| 2025-03-31 | $8.34M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $237.00K 10-Q · filed 2025-11-10 | $3.41M 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |